Modi's generics-only drugs plan worries health experts, Indian pharma sector

MUMBAI (Reuters) - India's plan to bring in a law to ensure doctors prescribe medicines only by their generic names risks proliferating the sale of substandard drugs in a country where regulation is already lax, doctors and pharmaceutical executives say.